| PERIOD ENDING | 31-May-08 | 29-Feb-08 | 30-Nov-07 | 31-Aug-07 | | Total Revenue | 835,217 | 693,643 | 780,674 | 713,922 | | Cost of Revenue | 347,598 | 327,722 | 333,289 | 327,247 | | | Gross Profit | 487,619 | 365,921 | 447,385 | 386,675 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 264,554 | 256,716 | 228,190 | 236,131 | | Non Recurring | 1,566 | 168,400 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 221,499 | (59,195) | 219,195 | 150,544 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,329 | 8,058 | 9,650 | 9,660 | | Earnings Before Interest And Taxes | 224,828 | (51,137) | 228,845 | 160,204 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 224,828 | (51,137) | 228,845 | 160,204 | | Income Tax Expense | 85,951 | (19,098) | 88,980 | 57,044 | | Minority Interest | 229 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 139,106 | (32,039) | 139,865 | 103,160 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 139,106 | (32,039) | 139,865 | 103,160 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $139,106 | ($32,039) | $139,865 | $103,160 |
|
7.87% Nasdaq 
Income Statement
